{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"partial-androgen-insensitivity","columns":[{"gene":"","key":"population-7e406c1aeab43f97fe9d","label":"Reifenstein syndrome","mondoId":"MONDO:0010720","onsetQualifier":null,"originColumnKey":"MONDO:0010720/OMIM:312300","originalViews":[{"key":"MONDO:0010720/OMIM:312300","label":"Reifenstein syndrome","scopeLabel":"OMIM:312300","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["11a4bcb363899f15973178137d0d81f4afa4bc97a0c47a3e97867953b2ce3e11","1a89c2ec68ee8e0969fd79a8599fb537509221ce07e0161baf234a18a101a5c0","1a89ff2281132b7fc664d3f02b070e1f6c54c36e413e82dbd42089e80d952e5f","506ee127666dc4bc9e6642d0f49ee3ce4e7054ec9230b9430d88603ed3695c8f","7f9c763075f77535e966cd559cb89424923ab79550feb426b5b4028c8871dd1e","852db84f9ca8b0070e4685bd9b5b9da8adaaaed2c8b9e0d58e54bdaf237b94c7","865404c390ec4f1a1ed2f4f1e03ab8639fb1341275d3e1c3b5deb5c4f64d8907","888d59210accd4fc94c3c384cfc27f1fb1ef4b8c3e96a8742f205f16868e48a1","8d3b9e41cd7fd4ee94d837710c32559b7503a12dfee05985fe8595caad2986cb","b3124daa6fca20f887aa7ad32dc772af51b06cc31cf54709d5d20cb7ed84c20b","fd4737b1fed481f9d83f2a89fb6d8dcfd425174775e9130c53230f824088b593"],"recordQualifiers":{},"scopeLabel":"OMIM:312300","sourceIds":["OMIM:312300"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-101874d317eca1b49d32","label":"Partial androgen insensitivity syndrome","mondoId":"MONDO:0010720","onsetQualifier":null,"originColumnKey":"MONDO:0010720/ORPHA:90797","originalViews":[{"key":"MONDO:0010720/ORPHA:90797","label":"Partial androgen insensitivity syndrome","scopeLabel":"ORPHA:90797","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0cec565760b074b5ce70e815246f0d5bea66de29da22115f45588b0b2ef2f5b9","16740f230b2953f75773edab25bfc58f2ee8a91932608ab54e6ff94c0c0f39ea","1d8c9aae1bb0adcb911eb005b6f97f45b67b9253d017acc543bb9274a7060d43","1edfce6efe67bea0dfa127a1f1062b22f9535963d4993b0817da8c08476a6031","2028fae2335065309247c523dbeba8686c3fa7a3015738f213066352c5388a48","2375552a5e23801015c8f3737ee58fcd9703d4bca0b4cdfadd66306a5cfec046","2b9451a6b7e48362e8de3985d63b5d9f084a9cf988f84d9850fb4be049e1cf1e","3b17ce7d9f215b2cbfde9a62cd44c5c873af4b72ebb1b6e63b3cf90cbe622e89","3b47ba4fc7d586c040eb34c07e5633a4fa9c6528969878fec32faef127a75fac","40c4cd82948ffc51525e7445b0f60c37c53f94141910d212635dfa6e62141d34","46b73f1adb0b3122a83d8b223878568b511346e5277919d6afe079728bf05a78","52f273e158f10da1cd0b53b57fade8b8a76d3f45e7e8238a26debb565dd1ed84","554a2fc7f835458bbfc6669123c1d7be9e6b7b0df38e8b4eca898c42d7eb0583","58bb6d34dfdc2fcb7c0aae895e7b3f911e76ce4907eb56cde943a6ac018f6bda","5c0a120258ab08a71c35ce002fe058d5145611bfe956e904937831cc6192f38e","6183da6dcbeefee7d68c7cf7e968ad207a201db6915faba7d4feb12b4b68a877","795878605a609064675c697ef60818b6c0bb080ac75cf430ab3d871cc60edad1","7bca1424f462ad0190372505e1e7a6d1d308523c93c0e6a83757122bb7e24594","7cc246e5a6cfd64c2017c3779a93d4f1798a652a659be2c5bb5953078e54b7ac","803c46484acbfcb827be513aacf01699aad59240b6fe57046b15a122372c44a4","ade895fb133c95f8f6508c417ec7bd2c1d35cc44ec0d4a98a06530cb9731c0ab","b920ca2ae1f25a3ee4e06fdc3e27316aeef356ed27eaa6e465ae5f10d702adb0","c7dfe590dddedccdc0146f4fc9a5fcd2b87ef630801c7341f4c71228d4c11493","d2a6344edbeb3227873d4cb1b5876c78fa7b3ef56d67ee13a764d6a4a8d9d133","d62407cc1f2f2e58fffa8bd577b9452a802223dbebc16f9143e10c0c06079de4","ea5680ce7023d94ae4e6c6d6b1c0585659d3c0021bc77c33f696bafdeab5fc15"],"recordQualifiers":{},"scopeLabel":"ORPHA:90797","sourceIds":["ORPHA:90797"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-7e406c1aeab43f97fe9d","population-101874d317eca1b49d32"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0025132","HP:0001547","HP:0009888","HP:0001620","HP:0012873","HP:0000062","HP:0010463"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":2,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":37,"sourceGroups":{"omim":8,"orphanet":26,"published":3}},"features":[{"hpoId":"HP:0025132","label":"Abnormal circulating estrogen level","primary":true},{"hpoId":"HP:0001547","label":"Abnormal rib cage morphology","primary":true},{"hpoId":"HP:0009888","label":"Abnormality of secondary sexual hair","primary":true},{"hpoId":"HP:0001620","label":"Abnormally high-pitched voice","primary":true},{"hpoId":"HP:0012873","label":"Absent vas deferens","primary":true},{"hpoId":"HP:0000062","label":"Ambiguous genitalia","primary":true},{"hpoId":"HP:0010463","label":"Aplasia of the ovary","primary":true},{"hpoId":"HP:0000151","label":"Aplasia of the uterus","primary":false},{"hpoId":"HP:0000027","label":"Azoospermia","primary":false},{"hpoId":"HP:0000048","label":"Bifid scrotum","primary":false},{"hpoId":"HP:0008689","label":"Bilateral cryptorchidism","primary":false},{"hpoId":"HP:0040314","label":"Blind vagina","primary":false},{"hpoId":"HP:0008665","label":"Clitoral hypertrophy","primary":false},{"hpoId":"HP:0000028","label":"Cryptorchidism","primary":false},{"hpoId":"HP:0011969","label":"Elevated circulating luteinizing hormone level","primary":false},{"hpoId":"HP:0025486","label":"Fused labia majora","primary":false},{"hpoId":"HP:0100728","label":"Germ cell neoplasia","primary":false},{"hpoId":"HP:0000771","label":"Gynecomastia","primary":false},{"hpoId":"HP:0000135","label":"Hypogonadism","primary":false},{"hpoId":"HP:0000047","label":"Hypospadias","primary":false},{"hpoId":"HP:0031102","label":"Increased circulating antimullerian hormone concentration","primary":false},{"hpoId":"HP:0025134","label":"Increased serum estradiol","primary":false},{"hpoId":"HP:0030088","label":"Increased serum testosterone level","primary":false},{"hpoId":"HP:0000789","label":"Infertility","primary":false},{"hpoId":"HP:0008189","label":"Insulin insensitivity","primary":false},{"hpoId":"HP:0003251","label":"Male infertility","primary":false},{"hpoId":"HP:0000037","label":"Male pseudohermaphroditism","primary":false},{"hpoId":"HP:0040307","label":"Male sexual dysfunction","primary":false},{"hpoId":"HP:0000054","label":"Micropenis","primary":false},{"hpoId":"HP:0000051","label":"Perineal hypospadias","primary":false},{"hpoId":"HP:0000786","label":"Primary amenorrhea","primary":false},{"hpoId":"HP:0100779","label":"Urogenital sinus anomaly","primary":false}],"ledeHtml":"Partial androgen insensitivity syndrome (PAIS) is a disorder of sex development that affects the growing reproductive and genital organs of a fetus. Androgen insensitivity refers to the inability of the body of an individual with a 46, XY karyotype (usually leading to normal male development) to properly respond to male sex hormones (androgens). In PAIS, the body partially responds to these hormones. Signs and symptoms of PAIS can vary greatly, causing a range of differences in genital appearance. Males may have hypospadias, small penis, and bifid scrotum. Females may have large clitoris, partial fusion of the labia, and gynecomastia (excessive development of male breasts). In the milder cases, the only symptom may be infertility. PAIS It is inherited in an X-linked recessive manner and is caused by genetic changes in the AR gene.","mondoId":"MONDO:0010720","node":{"canonicalSlug":"partial-androgen-insensitivity","comparisons":[{"documentSha256":"0b7d69813382e408e2f776082a04d2dedaf4c0ce990da225ccba510d2d1c334b","key":"legacy-androgen-insensitivity","kind":"legacy","label":"androgen insensitivity syndrome","memberIds":["MONDO:0010720","MONDO:0019154","MONDO:0021023"],"mondoId":"MONDO:0019154","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/androgen-insensitivity.0b7d69813382e408e2f776082a04d2dedaf4c0ce990da225ccba510d2d1c334b.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Partial androgen insensitivity syndrome","originalSourceId":"ORPHA:90797","paragraphs":["Partial androgen insensitivity syndrome (PAIS) is a disorder of sex development that affects the growing reproductive and genital organs of a fetus. Androgen insensitivity refers to the inability of the body of an individual with a 46, XY karyotype (usually leading to normal male development) to properly respond to male sex hormones (androgens). In PAIS, the body partially responds to these hormones. Signs and symptoms of PAIS can vary greatly, causing a range of differences in genital appearance. Males may have hypospadias, small penis, and bifid scrotum. Females may have large clitoris, partial fusion of the labia, and gynecomastia (excessive development of male breasts). In the milder cases, the only symptom may be infertility. PAIS It is inherited in an X-linked recessive manner and is caused by genetic changes in the AR gene."],"rawAttribution":"MONDO:0010720","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:39:31Z","upstream":"GARD:0005692","url":"https://rarediseases.info.nih.gov/diseases/5692"},"ownColumnKeys":["population-7e406c1aeab43f97fe9d","population-101874d317eca1b49d32"],"publication":"published","relationships":[{"kind":"parent","label":"androgen insensitivity syndrome","mondoId":"MONDO:0019154","slug":"androgen-insensitivity"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0cec565760b074b5ce70e815246f0d5bea66de29da22115f45588b0b2ef2f5b9","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000051","is_excluded":false,"label":"Perineal hypospadias","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"11a4bcb363899f15973178137d0d81f4afa4bc97a0c47a3e97867953b2ce3e11","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:312300","disease_name":"Reifenstein syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000027","is_excluded":false,"label":"Azoospermia","onset_id":null,"reference":"OMIM:312300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"16740f230b2953f75773edab25bfc58f2ee8a91932608ab54e6ff94c0c0f39ea","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030088","is_excluded":false,"label":"Increased serum testosterone level","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"1a89c2ec68ee8e0969fd79a8599fb537509221ce07e0161baf234a18a101a5c0","raw":{"aspect":"P","body_system":"breast","disease_id":"OMIM:312300","disease_name":"Reifenstein syndrome","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000771","is_excluded":false,"label":"Gynecomastia","onset_id":null,"reference":"PMID:1598912","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"1a89ff2281132b7fc664d3f02b070e1f6c54c36e413e82dbd42089e80d952e5f","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:312300","disease_name":"Reifenstein syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000789","is_excluded":false,"label":"Infertility","onset_id":null,"reference":"OMIM:312300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"1d8c9aae1bb0adcb911eb005b6f97f45b67b9253d017acc543bb9274a7060d43","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000054","is_excluded":false,"label":"Micropenis","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1edfce6efe67bea0dfa127a1f1062b22f9535963d4993b0817da8c08476a6031","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000786","is_excluded":false,"label":"Primary amenorrhea","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2028fae2335065309247c523dbeba8686c3fa7a3015738f213066352c5388a48","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000027","is_excluded":false,"label":"Azoospermia","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2375552a5e23801015c8f3737ee58fcd9703d4bca0b4cdfadd66306a5cfec046","raw":{"aspect":"P","body_system":"breast","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000771","is_excluded":false,"label":"Gynecomastia","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2b9451a6b7e48362e8de3985d63b5d9f084a9cf988f84d9850fb4be049e1cf1e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100728","is_excluded":false,"label":"Germ cell neoplasia","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b17ce7d9f215b2cbfde9a62cd44c5c873af4b72ebb1b6e63b3cf90cbe622e89","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008189","is_excluded":false,"label":"Insulin insensitivity","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b47ba4fc7d586c040eb34c07e5633a4fa9c6528969878fec32faef127a75fac","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0031102","is_excluded":false,"label":"Increased circulating antimullerian hormone concentration","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"40c4cd82948ffc51525e7445b0f60c37c53f94141910d212635dfa6e62141d34","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100779","is_excluded":false,"label":"Urogenital sinus anomaly","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"46b73f1adb0b3122a83d8b223878568b511346e5277919d6afe079728bf05a78","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0025486","is_excluded":false,"label":"Fused labia majora","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"506ee127666dc4bc9e6642d0f49ee3ce4e7054ec9230b9430d88603ed3695c8f","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:312300","disease_name":"Reifenstein syndrome","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0000028","is_excluded":false,"label":"Cryptorchidism","onset_id":null,"reference":"PMID:1598912","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"52f273e158f10da1cd0b53b57fade8b8a76d3f45e7e8238a26debb565dd1ed84","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0040307","is_excluded":false,"label":"Male sexual dysfunction","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"554a2fc7f835458bbfc6669123c1d7be9e6b7b0df38e8b4eca898c42d7eb0583","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000047","is_excluded":false,"label":"Hypospadias","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"58bb6d34dfdc2fcb7c0aae895e7b3f911e76ce4907eb56cde943a6ac018f6bda","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0009888","is_excluded":false,"label":"Abnormality of secondary sexual hair","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5c0a120258ab08a71c35ce002fe058d5145611bfe956e904937831cc6192f38e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001620","is_excluded":false,"label":"Abnormally high-pitched voice","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6183da6dcbeefee7d68c7cf7e968ad207a201db6915faba7d4feb12b4b68a877","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008665","is_excluded":false,"label":"Clitoral hypertrophy","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"795878605a609064675c697ef60818b6c0bb080ac75cf430ab3d871cc60edad1","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000048","is_excluded":false,"label":"Bifid scrotum","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7bca1424f462ad0190372505e1e7a6d1d308523c93c0e6a83757122bb7e24594","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0025134","is_excluded":false,"label":"Increased serum estradiol","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7cc246e5a6cfd64c2017c3779a93d4f1798a652a659be2c5bb5953078e54b7ac","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000151","is_excluded":false,"label":"Aplasia of the uterus","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"7f9c763075f77535e966cd559cb89424923ab79550feb426b5b4028c8871dd1e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:312300","disease_name":"Reifenstein syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000048","is_excluded":false,"label":"Bifid scrotum","onset_id":null,"reference":"OMIM:312300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"803c46484acbfcb827be513aacf01699aad59240b6fe57046b15a122372c44a4","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008689","is_excluded":false,"label":"Bilateral cryptorchidism","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"852db84f9ca8b0070e4685bd9b5b9da8adaaaed2c8b9e0d58e54bdaf237b94c7","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:312300","disease_name":"Reifenstein syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0012873","is_excluded":false,"label":"Absent vas deferens","onset_id":null,"reference":"OMIM:312300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"865404c390ec4f1a1ed2f4f1e03ab8639fb1341275d3e1c3b5deb5c4f64d8907","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:312300","disease_name":"Reifenstein syndrome","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0000051","is_excluded":false,"label":"Perineal hypospadias","onset_id":null,"reference":"PMID:1598912","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"888d59210accd4fc94c3c384cfc27f1fb1ef4b8c3e96a8742f205f16868e48a1","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:312300","disease_name":"Reifenstein syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000054","is_excluded":false,"label":"Micropenis","onset_id":null,"reference":"OMIM:312300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"8d3b9e41cd7fd4ee94d837710c32559b7503a12dfee05985fe8595caad2986cb","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:312300","disease_name":"Reifenstein syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000037","is_excluded":false,"label":"Male pseudohermaphroditism","onset_id":null,"reference":"OMIM:312300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"ade895fb133c95f8f6508c417ec7bd2c1d35cc44ec0d4a98a06530cb9731c0ab","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003251","is_excluded":false,"label":"Male infertility","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b3124daa6fca20f887aa7ad32dc772af51b06cc31cf54709d5d20cb7ed84c20b","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:312300","disease_name":"Reifenstein syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000135","is_excluded":false,"label":"Hypogonadism","onset_id":null,"reference":"OMIM:312300","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"b920ca2ae1f25a3ee4e06fdc3e27316aeef356ed27eaa6e465ae5f10d702adb0","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0040314","is_excluded":false,"label":"Blind vagina","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c7dfe590dddedccdc0146f4fc9a5fcd2b87ef630801c7341f4c71228d4c11493","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000062","is_excluded":false,"label":"Ambiguous genitalia","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d2a6344edbeb3227873d4cb1b5876c78fa7b3ef56d67ee13a764d6a4a8d9d133","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0025132","is_excluded":false,"label":"Abnormal circulating estrogen level","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d62407cc1f2f2e58fffa8bd577b9452a802223dbebc16f9143e10c0c06079de4","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0010463","is_excluded":false,"label":"Aplasia of the ovary","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ea5680ce7023d94ae4e6c6d6b1c0585659d3c0021bc77c33f696bafdeab5fc15","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:90797","disease_name":"Partial androgen insensitivity syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011969","is_excluded":false,"label":"Elevated circulating luteinizing hormone level","onset_id":null,"reference":"ORPHA:90797","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"fd4737b1fed481f9d83f2a89fb6d8dcfd425174775e9130c53230f824088b593","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:312300","disease_name":"Reifenstein syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001547","is_excluded":false,"label":"Abnormal rib cage morphology","onset_id":null,"reference":"OMIM:312300","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/5692\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0010720\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0005692</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Partial androgen insensitivity syndrome (PAIS) is a disorder of sex development that affects the growing reproductive and genital organs of a fetus. Androgen insensitivity refers to the inability of the body of an individual with a 46, XY karyotype (usually leading to normal male development) to properly respond to male sex hormones (androgens). In PAIS, the body partially responds to these hormones. Signs and symptoms of PAIS can vary greatly, causing a range of differences in genital appearance. Males may have hypospadias, small penis, and bifid scrotum. Females may have large clitoris, partial fusion of the labia, and gynecomastia (excessive development of male breasts). In the milder cases, the only symptom may be infertility. PAIS It is inherited in an X-linked recessive manner and is caused by genetic changes in the AR gene.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/5692\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"partial-androgen-insensitivity","sourceDocuments":[{"name":"GARD: Partial androgen insensitivity syndrome","reviewed":null,"source_release":"2026-10-25T03:39:31Z","url":"https://rarediseases.info.nih.gov/diseases/5692"},{"name":"MONDO: partial androgen insensitivity syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0010720"}],"sourceNote":"","synonyms":["androgen insensitivity syndrome, partial","androgen insensitivity, partial","androgen insensitivity, partial, with or without breast cancer","androgen insensitivity, partial, with or without breast cancer, X-linked recessive","androgen resistance syndrome, partial","familial incomplete Male pseudohermaphroditism, type 1","incomplete male pseudohermaphroditism","PAIS","pais","partial androgen resistance syndrome","pseudohermaphroditism, incomplete male, type I","Reifenstein syndrome","Reifenstein syndrome, partial","type I familial incomplete male pseudohermaphroditism"],"takeawayHtml":"","title":"partial androgen insensitivity syndrome"},"schemaVersion":1}
